BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17617631)

  • 21. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
    Dolan BP; Gibbs KD; Ostrand-Rosenberg S
    J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice.
    Bracke KR; D'hulst AI; Maes T; Moerloose KB; Demedts IK; Lebecque S; Joos GF; Brusselle GG
    J Immunol; 2006 Oct; 177(7):4350-9. PubMed ID: 16982869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A loss of antitumor therapeutic activity of CEA DNA vaccines is associated with the lack of tumor cells' antigen presentation to Ag-specific CTLs in a colon cancer model.
    Ahn E; Kim H; Han KT; Sin JI
    Cancer Lett; 2015 Jan; 356(2 Pt B):676-85. PubMed ID: 25449428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
    Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
    J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine.
    Timmerman JM; Levy R
    J Immunol; 2000 May; 164(9):4797-803. PubMed ID: 10779787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth.
    Fushimi T; Kojima A; Moore MA; Crystal RG
    J Clin Invest; 2000 May; 105(10):1383-93. PubMed ID: 10811846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
    Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
    Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of immunity to tumor-associated antigens following dendritic cell vaccination of cancer patients.
    Engleman EG; Fong L
    Clin Immunol; 2003 Jan; 106(1):10-5. PubMed ID: 12584045
    [No Abstract]   [Full Text] [Related]  

  • 30. Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs.
    Nakamura M; Iwahashi M; Nakamori M; Ueda K; Ojima T; Naka T; Ishida K; Yamaue H
    Oncology; 2005; 68(2-3):163-70. PubMed ID: 16006753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of potent CD8 T cell cytotoxicity by specific targeting of antigen to cross-presenting dendritic cells in vivo via murine or human XCR1.
    Hartung E; Becker M; Bachem A; Reeg N; Jäkel A; Hutloff A; Weber H; Weise C; Giesecke C; Henn V; Gurka S; Anastassiadis K; Mages HW; Kroczek RA
    J Immunol; 2015 Feb; 194(3):1069-79. PubMed ID: 25520399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of protective and therapeutic antitumour immunity using a novel tumour-associated antigen-specific DNA vaccine.
    Sun W; Qian H; Zhang X; Zhou C; Liang X; Wang D; Fu M; Ma W; Zhang S; Lin C
    Immunol Cell Biol; 2006 Oct; 84(5):440-7. PubMed ID: 16942487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
    Manches O; Plumas J; Lui G; Chaperot L; Molens JP; Sotto JJ; Bensa JC; Galili U
    Haematologica; 2005 May; 90(5):625-34. PubMed ID: 15921377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional expression of chemokine receptor CCR6 on human effector memory CD8+ T cells.
    Kondo T; Takata H; Takiguchi M
    Eur J Immunol; 2007 Jan; 37(1):54-65. PubMed ID: 17171755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity.
    Biragyn A; Tani K; Grimm MC; Weeks S; Kwak LW
    Nat Biotechnol; 1999 Mar; 17(3):253-8. PubMed ID: 10096292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photochemical Internalization of Peptide Antigens Provides a Novel Strategy to Realize Therapeutic Cancer Vaccination.
    Haug M; Brede G; Håkerud M; Nedberg AG; Gederaas OA; Flo TH; Edwards VT; Selbo PK; Høgset A; Halaas Ø
    Front Immunol; 2018; 9():650. PubMed ID: 29670624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted delivery of the ErbB2/HER2 tumor antigen to professional APCs results in effective antitumor immunity.
    Rohrbach F; Weth R; Kursar M; Sloots A; Mittrücker HW; Wels WS
    J Immunol; 2005 May; 174(9):5481-9. PubMed ID: 15843546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies specific for oncofetal antigen--immature laminin receptor protein: Effects on tumor growth and spread in two murine models.
    McClintock SD; Warner RL; Ali S; Chekuri A; Dame MK; Attili D; Knibbs RK; Aslam MN; Sinkule J; Morgan AC; Barsoum A; Smith LB; Beer DG; Johnson KJ; Varani J
    Cancer Biol Ther; 2015; 16(5):724-32. PubMed ID: 25799942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.